Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Reason
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Classification
Class II
Status
Ongoing
Lot
Lot # K24118, exp. date 10/31/2026
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Hikma Pharmaceuticals USA Inc. — Class II Recall | MedicineWatch US